Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency-Reference-Cited by-同舟云学术

Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiency

Published:2021-06-09 Issue:11 Volume:20 Page:1333-1349
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Galassi Andrea¹,Ciceri Paola²,Porata Giulia¹,Iatrino Rossella¹,Boni Brivio Giulia¹³,Fasulo Eliana¹,Magagnoli Lorenza¹³,Stucchi Andrea¹,Frittoli Michela¹³,Cara Anila¹³,Cozzolino Mario¹³

Affiliation:

1. Renal and Dialysis Unit, ASST Santi Paolo E Carlo, Milan, Italy

2. Renal Research Laboratory, Department of Nephrology, Dialysis and Renal Transplant, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico and Fondazione D’Amico per La Ricerca Sulle Malattie Renali, Milan, Italy

3. Department of Health and Science, University of Milan, Milan, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1931117

Reference110 articles.

1. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)

2. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool

3. Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

4. Bone metabolism and disease in chronic kidney disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs;Expert Opinion on Investigational Drugs;2024-06-19

2. Clinical features and new perspectives on follow-up and treatment of secondary hyperparathyroidism in patients with chronic kidney disease;2024-03-21

3. Vitamin D supplementation in people with chronic kidney disease;Kidney International;2023-10

4. Vitamin D as a drug: new therapeutic approaches;Pharmacia;2022-08-10

5. 1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study;Frontiers in Medicine;2022-03-02